Filing Flows › Foghorn Therapeutics (FHTX) › How it makes money
How Foghorn Therapeutics (FHTX) makes money
Foghorn Therapeutics (FHTX) made $16.1M of revenue in the second quarter 2026 (Q2 2026), +113% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q2 2026 | % of revenue |
|---|---|---|
| Revenue | $16.1M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q2 2026 | $16.1M | +113% |
| Q1 2026 | $3.3M | -45% |
| Q4 2025 | $9.2M | +224% |
| Q3 2025 | $8.2M | +4% |
| Q2 2025 | $7.6M | +10% |
| Q1 2025 | $6.0M | +18% |
| Q4 2024 | $2.9M | -50% |
From Foghorn Therapeutics' 10-Q filed Aug 6, 2026 (on EDGAR).
Questions
How does Foghorn Therapeutics make money?
Foghorn Therapeutics (FHTX) made $16.1M of revenue in the second quarter 2026 (Q2 2026), +113% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.